Abstract

To test the influence of the electrochemical ion gradient across mycoplasma membranes on the capacity of organisms to adhere to host cells, Mycoplasma gallisepticum cells were treated with valinomycin, carbonylcyanide m-chlorophenylhydrazone, and N,N'-dicyclohexylcarbodiimide (DCCD) singly or in combination. Uptake of [3H]tetraphenylphosphonium by the treated cells was employed as a measure of the effects of the ionophores on membrane potential. In the absence of K+, valinomycin increased, whereas carbonylcyanide m-chlorophenylhydrazone, and DCCD decreased [3H]tetraphenylphosphonium uptake. However, with a high level of K+ or with DCCD, uptake of [3H]tetraphenylphosphonium in the presence of valinomycin decreased below control levels, indicating that, generally, the ionophores affected membrane potential in the expected manner. The treated organisms were tested for their capacity to attach to glutaraldehyde-fixed human erythrocytes. DCCD was the best inhibitor of mycoplasma attachment, and in combination with valinomycin attachment, capacity decreased by about 40%. The combination of valinomycin plus carbonylcyanide m-chlorophenylhydrazone was less effective; it decreased attachment by about 15 to 25%. It was concluded that the dissipation of ion gradients across cell membranes decreases only partially mycoplasma adherence, in line with previous findings that isolated mycoplasma membranes retain the major part of the attachment capacity of intact cells.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.